Home/ Supplements/ Zinc/ I-Sight

I-Sight

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 62% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains antioxidants like N-Acetyl-L-Cysteine and Alpha-Lipoic Acid, alongside bilberry extract and zinc, which are researched for supporting ocular health. Evidence for these ingredients is generally moderate, focusing on reducing oxidative stress and supporting retinal function. The overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for I-Sight
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
62%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

35 mg (318% DV)
3.2× RDA — above typical dose (UL: 40 mg) 263 studies (A:6, B:134)
400 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
N-Acetyl-L-Cysteine
200 mg
Market median: 100.0mg (120 products)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
100 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
30 mg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
6 mg
Market median: 10.0mg (35 products) 6 studies (A:0, B:2)

Other Ingredients

Capsule Stearic Acid Microcrystalline Cellulose Silica Magnesium Stearate Medium-Chain Triglyceride Oil
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take two capsules daily, or as directed by your healthcare professional.

Warnings & Precautions

Consult your healthcare professional prior to use.

Individuals taking medication should discuss potential interactions with their healthcare professional.

Do not use if tamper seal is damaged. The labeling on this product does not comply with California's Proposition 65. Therefore, this product may not be sold in California.

Storage: Keep closed in a cool, dry place out of reach of children.

Formulation Notes

I-Sight is a groundbreaking supplement for the care and support of the eyes. Developed in conjunction with respected Opthalmologists, this formula allows for the increased intake of specific ocular antioxidants in order to maintain healthy retina, lens and eyesight function during the aging years. Significant research confirms the benefits of these ingredients.

Formulated to Exclude: Wheat, gluten, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or preservatives.

Additional Information

Professional use only Not for resale on third-party websites, including, but not limited to, Amazon and eBay.

Storage: Keep closed in a cool, dry place out of reach of children.

Proprietary Ocular Formula

ePV

Exclusive Professional Formulas

Vegetarian Caps

GMP Compliant Third-party verified

This package is completely recyclable

Metadata

Product Details

UPC / SKU8 71149 00037 0
DSLD Entry Date2020-11-21
Product TypeOther Combinations
FormCapsule
BrandXYMOGEN
DSLD ID240228
Data Updated2026-04-11
Research

Research Evidence

397
Research Sources
55
Avg Quality
200
Meta Analysis
68
Rct
58
Systematic Review
53
Clinical Trial
9
Cochrane Review
2
Narrative Review
2
Regulatory Source
1
Observational
1
Other
1
Openfda Safety
A Zinc supplementation for improving pregnancy and infant outcome
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
Narrative Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Oral zinc for treating diarrhoea in children
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2021 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2010 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Compression bandages or stockings versus no compression for treating venous leg ulcers
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for mental and motor development in children
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Zinc for the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Zinc →
Compare

Similar Products

View all Zinc products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.